Catalyst Pharmaceutical Partners Inc buy Citigroup Inc.
Start price
14.03.24
/
50%
€15.01
Target price
14.03.25
€24.74
Performance (%)
26.78%
End price
15.03.25
€19.03
Summary
This prediction ended on 15.03.25 with a price of €19.03. The prediction had a final performance of 26.78%. Citigroup_Inc_ has a follow-up prediction for Catalyst Pharmaceutical Partners Inc where he still thinks Catalyst Pharmaceutical Partners Inc is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 3.069% | 3.069% | -10.760% |
| iShares Core DAX® | -0,48 % | -12,06 % | -2,04 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % | 13,43 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % | 23,57 % |
| iShares S&P 500 | -2,27 % | -5,05 % | 8,65 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $27.00 price target on the stock.
Ratings data for CPRX provided by MarketBeat
In the thread Trading Catalyst Pharmaceutical Partners Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€18.50
07.11.25
07.11.25
€28.60
07.11.26
07.11.26
9.87%
27.03.26
27.03.26
Stopped prediction by Citigroup_Inc_ for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.55
03.03.26
03.03.26
€29.92
03.03.27
03.03.27
-1.12%
27.03.26
27.03.26